Key Dates
- Board Meeting Date: Friday, August 7, 2026
- Quarter Ended: June 30, 2026 (Q1 FY27)
- Trading Window Closure Period: From July 1, 2026 to August 9, 2026
- Disclosure Date: July 28, 2026
Agenda Items
The Board of Directors of Aarti Pharmalabs Limited will consider and approve:
- Unaudited Financial Results (Standalone) for the quarter ended June 30, 2026
- Unaudited Financial Results (Consolidated) for the quarter ended June 30, 2026
- Limited Review Reports of the Auditors for the corresponding period
Parties Involved
- Stock Exchanges: BSE Limited (Scrip Code: 543748) and National Stock Exchange of India Limited (Symbol: AARTIPHARM)
Financial Impact
Financial impact not quantified in the disclosure. The meeting is for consideration and approval of quarterly financial results.